Cargando…
Real-Life Benefit of Omalizumab in Improving Control of Bronchial Asthma During COVID-19 Pandemic
Biologic therapy is recommended by Global Initiative for Asthma (GINA) guidelines in asthma patients not controlled with maximal inhaled therapy corresponding to GINA step 4. Omalizumab is an anti- immunoglobulin E (IgE) monoclonal antibody and the first biological available for the add-on treatment...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Cureus
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8371356/ https://www.ncbi.nlm.nih.gov/pubmed/34422507 http://dx.doi.org/10.7759/cureus.17268 |